Demographic group comparison
| Factor | Bevacizumab only | Ranibizumab only | Ranibizumab and bevacizumab |
| No of eyes | 101 | 96 | 18 |
| Age (mean) | 76.6 (SD=12.3) | 79.2 (SD=9.2) | 77 (SD=8.5) |
| Sex (percentage male) | 34.7% (n=35) | 43.7% (n=42) | 38.8% (n=7) |
| Prevalence of pre-existing glaucoma | 9.9% (n=10) | 10.4% (n=10) | 5.6% (n=1) |